- Gamma Knife technology plays a crucial role in non-invasive neurosurgery, enabling highly precise radiation delivery to brain lesions while minimizing damage to surrounding healthy tissue, significantly improving patient recovery and outcomes
- The demand for gamma knife systems is rising due to increasing incidence of neurological disorders, growing preference for minimally invasive procedures, and expanding application of stereotactic radiosurgery in treating brain tumors, AVMs, and trigeminal neuralgia
- North America is expected to dominate the gamma knife market with the largest market share of 44.87%, driven by advanced neurosurgical centers, high healthcare spending, supportive reimbursement policies, and rapid adoption of precision oncology technologies
- Asia-Pacific is projected to register the highest growth rate in the gamma knife market during the forecast period, fueled by rising healthcare infrastructure investments, improved access to specialized treatments, and increased awareness of non-surgical brain treatment options across countries such as India, China, and Japan
- The brain metastasis segment is expected to dominate the usability segment with the largest market share of 46.94% in 2025, due to the rising incidence of brain metastases, the effectiveness of gamma knife in delivering targeted radiation with minimal damage to healthy tissue, and growing preference for non-invasive treatment options
